LysM-cre mice have been extensively used for deletion in macrophages, and in particular, KCs in liver disease contexts (Greenhalgh et al, 2015; Beattie et al, 2016; Shi et al, 2018; Puchalska et al, 2019). Here, TBCE is linked to liver disorder.